August 24, 2016 10:25 PM ET

Pharmaceuticals

Company Overview of Avexa Ltd.

Executive Profile

Iain MacGregor Crawford Kirkwood MA (Hons) (Oxon), FCPA, CA, MAICD

Executive Chairman, Chairman of Audit Committee and Member of Remuneration & Nomination Committee, Avexa Ltd.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 10 different industries.

See Board Relationships
64A$96,250

Background

Mr. Iain MacGregor Crawford Kirkwood, MA(Hons)(Oxon), FCPA, CA, MAICD, is the Co-Owner of Marbrijen Pty Ltd. Mr. Kirkwood served as a Consultant of Clinuvel Pharmaceuticals Limited (formerly known as EpiTan Ltd.). He served as Chief Financial Officer, Chief Administrative Officer and Company Secretary of Clinuvel Pharmaceuticals Limited. He served as the Chief Executive Officer and Managing Director of Clinuvel Pharmaceuticals Limited from February 1, 2005 to November ...

Corporate Headquarters

61-63 Camberwell Road
Hawthorn East, Victoria 3123

Australia

Phone: 61 3 8888 1040
Fax: --

Board Members Memberships

Non-Executive Director
Independent Non Executive Director
2004-Present
Non Executive Director, Chairman of Audit & Risk Management Committee, Member of Nomination & Governance Committee and Member of Remuneration Committee
2007-Present
Non-Executive Chairman
2010-Present
Executive Chairman, Chairman of Audit Committee and Member of Remuneration & Nomination Committee
2010-Present
Non-Executive Chairman

Education

MA
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash CompensationA$96,250
Total Calculated CompensationA$96,250
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$1.3M
John F. Milligan Ph.D.Chief Executive Officer, President and Director
Gilead Sciences Inc.
$1.2M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co., Inc.
$1.5M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Avexa Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.